{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T11:41:07Z","timestamp":1769082067766,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/pr.2017.41","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T18:40:21Z","timestamp":1489430421000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro"],"prefix":"10.1038","volume":"82","author":[{"given":"Simone S","family":"Sch\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Wisgrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Herndl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Spittler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"F\u00f6rster-Waldl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambis","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris W","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"key":"BFpr201741_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.inf.0000168749.82105.64","volume":"24","author":"BJ Stoll","year":"2005","unstructured":"Stoll BJ, Hansen NI, Higgins RD et al, Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002\u20132003. Pediatr Infect Dis J 2005;24:635\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr201741_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.V92.1.11.413a39_11_18","volume":"92","author":"IM Chalmers","year":"1998","unstructured":"Chalmers IM, Janossy G, Contreras M, Navarrete C . Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998;92:11\u20138.","journal-title":"Blood"},{"key":"BFpr201741_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1086\/509892","volume":"195","author":"K Sadeghi","year":"2007","unstructured":"Sadeghi K, Berger A, Langgartner M et al, Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007;195:296\u2013302.","journal-title":"J Infect Dis"},{"key":"BFpr201741_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1189\/jlb.1011525","volume":"93","author":"SS Sch\u00fcller","year":"2013","unstructured":"Sch\u00fcller SS, Sadeghi K, Wisgrill L et al, Preterm neonates display altered plasmacytoid dendritic cell function and morphology. J Leukoc Biol 2013;93:781\u20138.","journal-title":"J Leukoc Biol"},{"key":"BFpr201741_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nri2075","volume":"7","author":"O Levy","year":"2007","unstructured":"Levy O . Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379\u201390.","journal-title":"Nat Rev Immunol"},{"key":"BFpr201741_CR6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4049\/jimmunol.150.4.1205","volume":"150","author":"T Krakauer","year":"1993","unstructured":"Krakauer T, Oppenheim JJ . IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 1993;150:1205\u201311.","journal-title":"J Immunol"},{"key":"BFpr201741_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1189\/jlb.4A0116-001RR","volume":"100","author":"L Wisgrill","year":"2016","unstructured":"Wisgrill L, Groschopf A, Herndl E et al, Reduced TNF-\u03b1 response in preterm neonates is associated with impaired nonclassic monocyte function. J Leukoc Biol 2016;100:607\u201312.","journal-title":"J Leukoc Biol"},{"key":"BFpr201741_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1203\/01.PDR.0000163397.53466.0F","volume":"58","author":"E F\u00f6rster-Waldl","year":"2005","unstructured":"F\u00f6rster-Waldl E, Sadeghi K, Tamandl D et al, Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res 2005;58:121\u20134.","journal-title":"Pediatr Res"},{"key":"BFpr201741_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/00008480-200306000-00009","volume":"15","author":"SA Lakhani","year":"2003","unstructured":"Lakhani SA, Bogue CW . Toll-like receptor signaling in sepsis. Curr Opin Pediatr 2003;15:278\u201382.","journal-title":"Curr Opin Pediatr"},{"key":"BFpr201741_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1017\/S0265021507003389","volume":"42","author":"M Shimaoka","year":"2008","unstructured":"Shimaoka M, Park EJ . Advances in understanding sepsis. Eur J Anaesthesiol Suppl 2008;42:146\u201353.","journal-title":"Eur J Anaesthesiol Suppl"},{"key":"BFpr201741_CR11","first-page":"CD004205","volume":"3","author":"M Pammi","year":"2015","unstructured":"Pammi M, Haque KN . Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2015;3:CD004205.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFpr201741_CR12","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1097\/INF.0000000000000698","volume":"34","author":"AE Shabaan","year":"2015","unstructured":"Shabaan AE, Nasef N, Shouman B, Nour I, Mesbah A, Abdel-Hady H . Pentoxifylline therapy for late-onset sepsis in preterm infants: a randomized controlled trial. Pediatr Infect Dis J 2015;34:e143\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"BFpr201741_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0171-2985(11)80356-6","volume":"187","author":"P Zabel","year":"1993","unstructured":"Zabel P, Schade FU, Schlaak M . Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993;187:447\u201363.","journal-title":"Immunobiology"},{"key":"BFpr201741_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0192-0561(97)85556-7","volume":"18","author":"CL D\u2019Hellencourt","year":"1996","unstructured":"D\u2019Hellencourt CL, Diaw L, Cornillet P, Guenounou M . Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol 1996;18:739\u201348.","journal-title":"Int J Immunopharmacol"},{"key":"BFpr201741_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2567.1997.00435.x","volume":"90","author":"P Neuner","year":"1997","unstructured":"Neuner P, Klosner G, Pourmojib M, Knobler R, Schwarz T . Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Immunology 1997;90:435\u20139.","journal-title":"Immunology"},{"key":"BFpr201741_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1074-7613(00)80423-9","volume":"6","author":"W Wang","year":"1997","unstructured":"Wang W, Tam WF, Hughes CC, Rath S, Sen R . c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 1997;6:165\u201374.","journal-title":"Immunity"},{"key":"BFpr201741_CR17","first-page":"367","volume":"3","author":"J Szymura\u2010Oleksiak","year":"1997","unstructured":"Szymura\u2010Oleksiak J, Bury J, Lauterbach R, Paw\u0142owski M . Serum Concentrations of pentoxifylline and its metabolites in premature infants with sepsis when administered by continuous intravenous infusion. Pharm Pharmacol Commun 1997;3:367\u201371.","journal-title":"Pharm Pharmacol Commun"},{"key":"BFpr201741_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00003246-199904000-00042","volume":"27","author":"R Lauterbach","year":"1999","unstructured":"Lauterbach R, Pawlik D, Kowalczyk D, Ksyc\u00ednski W, Helwich E, Zembala M . Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 1999;27:807\u201314.","journal-title":"Crit Care Med"},{"key":"BFpr201741_CR19","first-page":"575","volume":"59","author":"R Coimbra","year":"2005","unstructured":"Coimbra R, Melbostad H, Loomis W, Tobar M, Hoyt DB . Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. J Trauma 2005;59:575\u201382.","journal-title":"J Trauma"},{"key":"BFpr201741_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0162-3109(00)00249-6","volume":"49","author":"J Marcinkiewicz","year":"2000","unstructured":"Marcinkiewicz J, Grabowska A, Lauterbach R, Bobek M . Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages. Immunopharmacology 2000;49:335\u201343.","journal-title":"Immunopharmacology"},{"key":"BFpr201741_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-5728(95)00176-X","volume":"64","author":"P Rieckmann","year":"1996","unstructured":"Rieckmann P, Weber F, G\u00fcnther A et al, Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol 1996;64:193\u2013200.","journal-title":"J Neuroimmunol"},{"key":"BFpr201741_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","volume":"9","author":"S Sanjabi","year":"2009","unstructured":"Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA . Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009;9:447\u201353.","journal-title":"Curr Opin Pharmacol"},{"key":"BFpr201741_CR23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.177.4.1205","volume":"177","author":"M Howard","year":"1993","unstructured":"Howard M, Muchamuel T, Andrade S, Menon S . Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205\u20138.","journal-title":"J Exp Med"},{"key":"BFpr201741_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00918147","volume":"12","author":"M Howard","year":"1992","unstructured":"Howard M, O\u2019Garra A, Ishida H, de Waal Malefyt R, de Vries J . Biological properties of interleukin 10. J Clin Immunol 1992;12:239\u201347.","journal-title":"J Clin Immunol"},{"key":"BFpr201741_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2249.2008.03737.x","volume":"154","author":"DD Danikas","year":"2008","unstructured":"Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA . Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol 2008;154:87\u201397.","journal-title":"Clin Exp Immunol"},{"key":"BFpr201741_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000244245","volume":"68","author":"AE Falconer","year":"1995","unstructured":"Falconer AE, Carr R, Edwards SW . Impaired neutrophil phagocytosis in preterm neonates: lack of correlation with expression of immunoglobulin or complement receptors. Biol Neonate 1995;68:264\u20139.","journal-title":"Biol Neonate"},{"key":"BFpr201741_CR27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.humimm.2007.06.004","volume":"68","author":"M Lingnau","year":"2007","unstructured":"Lingnau M, H\u00f6flich C, Volk H-D, Sabat R, D\u00f6cke W-D . Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes. Hum Immunol 2007;68:730\u20138.","journal-title":"Hum Immunol"},{"key":"BFpr201741_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00024382-199812000-00002","volume":"10","author":"BD Shames","year":"1998","unstructured":"Shames BD, Selzman CH, Meldrum DR et al, Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock 1998;10:389\u201394.","journal-title":"Shock"},{"key":"BFpr201741_CR29","doi-asserted-by":"crossref","unstructured":"Ward PA, Lentsch AB . Endogenous regulation of the acute inflammatory response. Mol Cell Biochem 234\u2013235:225\u20138.","DOI":"10.1007\/978-1-4615-1087-1_26"},{"key":"BFpr201741_CR30","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.4049\/jimmunol.177.3.1956","volume":"177","author":"O Levy","year":"2006","unstructured":"Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR . The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 2006;177:1956\u201366.","journal-title":"J Immunol"},{"key":"BFpr201741_CR31","first-page":"595","volume":"22","author":"JM Anaya","year":"1995","unstructured":"Anaya JM, Espinoza LR . Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory\/immunomodulatory drug potentially useful in some rheumatic diseases. J Rheumatol 1995;22:595\u20139.","journal-title":"J Rheumatol"},{"key":"BFpr201741_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/SHK.0b013e3181cdc3e2","volume":"34","author":"S Kreth","year":"2010","unstructured":"Kreth S, Ledderose C, Luchting B, Weis F, Thiel M . Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways. Shock 2010;34:10\u20136.","journal-title":"Shock"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201741.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201741","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/pr.2017.41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/pr201741.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T16:18:12Z","timestamp":1692721092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["BFpr201741"],"URL":"https:\/\/doi.org\/10.1038\/pr.2017.41","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,24]]},"assertion":[{"value":"24 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}